組織工学による皮膚代替物の世界市場レポート 2025年

組織工学による皮膚代替物市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.6％で28億2,000万米ドルに成長します。予測期間の成長は、アプリケーションの拡大、規制当局の承認と基準、持続可能性への重点化、専門クリニックの成長、教育プログラムとトレーニングの拡大に起因しています。予測期間における主な動向としては、生体材料の進歩、細胞治療の強化、市販後サーベイランスとデータ収集、個別化医療の進歩、消費者の嗜好の変化などが挙げられます。

事故の発生率の上昇が、今後の組織工学的皮膚代替物市場の成長を促進すると予測されます。このような事故の増加は、交通量の増加、脇見運転、不十分な道路整備、運転中のモバイル機器の使用増加などの要因に起因しています。組織工学的皮膚代替物は、損傷した皮膚に機能的で生体適合性のある代替物を提供し、治癒を早め、感染症や瘢痕のような合併症を最小限に抑えます。例えば、2024年6月、米国を拠点とする非営利団体である道路安全保険協会（Insurance Institute for Highway Safety and Highway Loss Data Institute）は、自動車事故で死亡した70歳以上の人の数が、2021年の5,245人から2022年には5,626人に増加したと報告しました。したがって、事故の発生率の増加が組織工学的皮膚代替物市場の成長を促進しています。

組織工学的皮膚代替物市場の主なプレーヤーは、複雑な皮膚層を作成する精度と効率を向上させ、それによって皮膚代替物と天然皮膚との統合を強化するために、バイオプリンティングのような先進技術の開発に集中しています。バイオプリンティング技術は、細胞、生体材料、成長因子を積層することにより、複雑な皮膚構造を正確に作製することを可能にし、より優れた組織再生と既存の皮膚との統合を促進します。例えば、2022年11月、インドを拠点とする組織・臓器用3DバイオプリンターのメーカーであるAvay Biosciences Private Limitedは、ヒト組織をプリントすることができる固有のMito Plus 3Dプリンターを発表しました。このプリンターはバイオインクと呼ばれる特殊な材料を使用して生体組織を再現し、UV硬化オプション、HEPAフィルター、精密な温度制御などの機能を備えており、製薬や美容分野での創薬や検査など多様な用途に適しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界組織工学による皮膚代替物PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の組織工学による皮膚代替物市場：成長率分析
• 世界の組織工学による皮膚代替物市場の実績：規模と成長, 2019-2024
• 世界の組織工学による皮膚代替物市場の予測：規模と成長, 2024-2029, 2034F
• 世界組織工学による皮膚代替物総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の組織工学による皮膚代替物市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 無細胞皮膚代替品
• 生物学的皮膚代替品
• 細胞性皮膚代替物
• 合成皮膚代替品
• 世界の組織工学による皮膚代替物市場：素材別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 合成
• 天然
• 世界の組織工学による皮膚代替物市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• レーザー支援バイオプリンティング
• 3次元（3D）
• ロボット技術
• その他のテクノロジー
• 世界の組織工学による皮膚代替物市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 慢性創傷
• 急性創傷
• その他の用途
• 世界の組織工学による皮膚代替物市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 外来手術センター
• 調査室
• 世界の組織工学による皮膚代替物市場無細胞皮膚代替品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 脱細胞化真皮
• コラーゲンベースのスキャフォールド
• 羊膜
• 世界の組織工学による皮膚代替物市場、生物学的皮膚代替品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 生細胞を含む代替物
• 同種皮膚移植
• 異種皮膚移植
• 世界の組織工学による皮膚代替物市場細胞代替皮膚のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 培養上皮自家移植（CEA）
• 細胞入り真皮代替品
• 幹細胞由来の皮膚構造
• 世界の組織工学による皮膚代替物市場合成皮膚代替品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• ポリマーベースの足場
• 生分解性足場
• ハイドロゲルベースの代替品

第7章 地域別・国別分析

• 世界の組織工学による皮膚代替物市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の組織工学による皮膚代替物市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 組織工学による皮膚代替物市場：競合情勢
• 組織工学による皮膚代替物市場：企業プロファイル
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • DePuy Synthes Overview, Products and Services, Strategy and Financial Analysis
  • Smith & Nephew Plc Overview, Products and Services, Strategy and Financial Analysis
  • ConvaTec Group PLC Overview, Products and Services, Strategy and Financial Analysis
  • Mallinckrodt Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Integra LifeSciences Holdings Corporation
• Gunze Limited
• Organogenesis Inc.
• LifeNet Health Inc.
• MiMedx Group Inc.
• Vericel Corporation
• AlloSource Inc.
• Sientra Inc.
• PolyNovo Limited
• Avita Medical Limited
• Tissue Regenix Group
• Amarantus Bioscience Holdings Inc.
• PolarityTE
• Promethean LifeSciences Inc.
• Regenicin Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 組織工学による皮膚代替物市場2029：新たな機会を提供する国
• 組織工学による皮膚代替物市場2029：新たな機会を提供するセグメント
• 組織工学による皮膚代替物市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

A tissue-engineered skin substitute is a lab-created material designed to replicate the properties of natural skin. It combines cells, biomaterials, and growth factors to create a functional, skin-like layer that aids in healing and restoring skin integrity for patients with severe wounds or burns.

The main types of tissue-engineered skin substitutes include acellular skin substitutes, biologic skin substitutes, cellular skin substitutes, and synthetic skin substitutes. Acellular skin substitutes are constructed from materials with all cells removed, leaving a scaffold that supports the body's own cells in growing and repairing the skin. These substitutes can be made from both synthetic and natural materials using various technologies such as laser-assisted bio-printing, 3D printing, and robotic technology. They are used for different applications, including chronic and acute wounds. End users of these products include hospitals, specialty clinics, ambulatory surgical centers, and research laboratories.

The tissue-engineered skin substitutes market research report is one of a series of new reports from The Business Research Company that provides tissue-engineered skin substitutes market statistics, including tissue-engineered skin substitutes industry global market size, regional shares, competitors with a tissue-engineered skin substitutes market share, detailed tissue-engineered skin substitutes market segments, market trends and opportunities, and any further data you may need to thrive in the tissue-engineered skin substitutes industry. This tissue-engineered skin substitutes market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The tissue engineered skin substitute market size has grown strongly in recent years. It will grow from $1.86 billion in 2024 to $2.03 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increasing funding from government agencies, increasing focus on personalized medicine, increasing funding from government agencies.

The tissue engineered skin substitute market size is expected to see strong growth in the next few years. It will grow to $2.82 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the expansion of applications, regulatory approvals and standards, greater focus on sustainability, growth in specialized clinics, and expansion of educational programs and training. Major trends in the forecast period include advancements in biomaterials, enhanced cellular therapies, post-market surveillance and data collection, advancements in personalized medicine and shifts in consumer preferences.

The rising incidence of accidents is projected to drive the growth of the tissue-engineered skin substitute market in the future. This increase in accidents can be attributed to factors such as higher traffic volumes, distracted driving, insufficient road maintenance, and the growing use of mobile devices while driving. Tissue-engineered skin substitutes offer a functional and biocompatible alternative for damaged skin, facilitating faster healing and minimizing complications like infections and scarring. For example, in June 2024, the Insurance Institute for Highway Safety and Highway Loss Data Institute, a U.S.-based nonprofit organization, reported that the number of individuals aged 70 and older who died in motor vehicle crashes rose from 5,245 in 2021 to 5,626 in 2022. Therefore, the increasing incidence of accidents is driving the growth of the tissue-engineered skin substitute market.

Key players in the tissue-engineered skin substitute market are concentrating on the development of advanced technologies like bioprinting to improve the precision and efficiency of creating complex skin layers, thereby enhancing the integration of skin substitutes with natural skin. Bioprinting technology allows for the accurate fabrication of intricate skin structures by layering cells, biomaterials, and growth factors, which fosters better tissue regeneration and integration with existing skin. For example, in November 2022, Avay Biosciences Private Limited, an India-based manufacturer of 3D bioprinters for tissues and organs, introduced the indigenous Mito Plus 3D printer, capable of printing human tissues. This printer uses specialized materials known as bioinks to replicate living tissues and is equipped with features like UV curing options, HEPA filters, and precise temperature control, making it suitable for diverse applications, including drug discovery and testing in the pharmaceutical and cosmetology sectors.

In March 2023, Aziyo Biologics Inc., a US-based regenerative medicine company, entered into a partnership with Sientra Inc. This collaboration is focused on expanding the distribution of Aziyo's SimpliDerm product line, a tissue-engineered skin substitute. Under this agreement, Sientra will have non-exclusive rights to market, sell, and distribute SimpliDerm in the US for specific applications in reconstruction surgery. Sientra Inc. specializes in aesthetic medicine and plastic surgery implants.

Major companies operating in the tissue engineered skin substitute market are Stryker Corporation, DePuy Synthes, Smith & Nephew Plc, ConvaTec Group PLC, Mallinckrodt Pharmaceuticals plc, Integra LifeSciences Holdings Corporation, Gunze Limited, Organogenesis Inc., LifeNet Health Inc., MiMedx Group Inc., Vericel Corporation, AlloSource Inc., Sientra Inc., PolyNovo Limited, Avita Medical Limited, Tissue Regenix Group, Amarantus Bioscience Holdings Inc., PolarityTE, Promethean LifeSciences Inc., Regenicin Inc.

North America was the largest region in the tissue engineered skin substitute market in 2023. The regions covered in the tissue engineered skin substitute market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tissue engineered skin substitute market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The tissue-engineered skin substitute market consists of sales of products including apligraf, dermagraft, epicel, matristem, and stratagraft. Values in this market are factory gate values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Engineered Skin Substitute Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tissue engineered skin substitute market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue engineered skin substitute ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tissue engineered skin substitute market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Acellular Skin Substitutes; Biologic Skin Substitute; Cellular Skin Substitutes; Synthetic Skin Substitutes
• 2) By Material: Synthetic; Natural
• 3) By Technology: Laser Assisted Bio-Printing; 3-Dimensional (3D); Robotic Technology; Other Technologies
• 4) By Application: Chronic Wounds; Acute Wounds; Other Applications
• 5) By End User: Hospital; Specialty Clinics; Ambulatory Surgical Centers; Research Laboratory
• Subsegments:
• 1) By Acellular Skin Substitutes: Decellularized Dermis; Collagen-Based Scaffolds; Amniotic Membrane
• 2) By Biologic Skin Substitutes: Living Cell-Containing Substitutes; Allogeneic Skin Grafts; Xenogeneic Skin Grafts
• 3) By Cellular Skin Substitutes: Cultured Epithelial Autografts (CEA); Dermal Substitutes with Cells; Stem Cell-Derived Skin Constructs
• 4) By Synthetic Skin Substitutes: Polymer-Based Scaffolds; Biodegradable Scaffolds; Hydrogel-Based Substitutes
• Companies Mentioned: Stryker Corporation; DePuy Synthes; Smith & Nephew Plc; ConvaTec Group PLC; Mallinckrodt Pharmaceuticals plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tissue Engineered Skin Substitute Market Characteristics

3. Tissue Engineered Skin Substitute Market Trends And Strategies

4. Tissue Engineered Skin Substitute Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tissue Engineered Skin Substitute Growth Analysis And Strategic Analysis Framework

• 5.1. Global Tissue Engineered Skin Substitute PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Tissue Engineered Skin Substitute Market Growth Rate Analysis
• 5.4. Global Tissue Engineered Skin Substitute Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Tissue Engineered Skin Substitute Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Tissue Engineered Skin Substitute Total Addressable Market (TAM)

6. Tissue Engineered Skin Substitute Market Segmentation

• 6.1. Global Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acellular Skin Substitutes
• Biologic Skin Substitute
• Cellular Skin Substitutes
• Synthetic Skin Substitutes
• 6.2. Global Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synthetic
• Natural
• 6.3. Global Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laser Assisted Bio-Printing
• 3-Dimensional (3D)
• Robotic Technology
• Other Technologies
• 6.4. Global Tissue Engineered Skin Substitute Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chronic Wounds
• Acute Wounds
• Other Applications
• 6.5. Global Tissue Engineered Skin Substitute Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital
• Specialty Clinics
• Ambulatory Surgical Centers
• Research Laboratory
• 6.6. Global Tissue Engineered Skin Substitute Market, Sub-Segmentation Of Acellular Skin Substitutes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Decellularized Dermis
• Collagen-Based Scaffolds
• Amniotic Membrane
• 6.7. Global Tissue Engineered Skin Substitute Market, Sub-Segmentation Of Biologic Skin Substitutes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Living Cell-Containing Substitutes
• Allogeneic Skin Grafts
• Xenogeneic Skin Grafts
• 6.8. Global Tissue Engineered Skin Substitute Market, Sub-Segmentation Of Cellular Skin Substitutes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cultured Epithelial Autografts (CEA)
• Dermal Substitutes with Cells
• Stem Cell-Derived Skin Constructs
• 6.9. Global Tissue Engineered Skin Substitute Market, Sub-Segmentation Of Synthetic Skin Substitutes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Polymer-Based Scaffolds
• Biodegradable Scaffolds
• Hydrogel-Based Substitutes

7. Tissue Engineered Skin Substitute Market Regional And Country Analysis

• 7.1. Global Tissue Engineered Skin Substitute Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Tissue Engineered Skin Substitute Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tissue Engineered Skin Substitute Market

• 8.1. Asia-Pacific Tissue Engineered Skin Substitute Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tissue Engineered Skin Substitute Market

• 9.1. China Tissue Engineered Skin Substitute Market Overview
• 9.2. China Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tissue Engineered Skin Substitute Market

• 10.1. India Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tissue Engineered Skin Substitute Market

• 11.1. Japan Tissue Engineered Skin Substitute Market Overview
• 11.2. Japan Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tissue Engineered Skin Substitute Market

• 12.1. Australia Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tissue Engineered Skin Substitute Market

• 13.1. Indonesia Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tissue Engineered Skin Substitute Market

• 14.1. South Korea Tissue Engineered Skin Substitute Market Overview
• 14.2. South Korea Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tissue Engineered Skin Substitute Market

• 15.1. Western Europe Tissue Engineered Skin Substitute Market Overview
• 15.2. Western Europe Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tissue Engineered Skin Substitute Market

• 16.1. UK Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tissue Engineered Skin Substitute Market

• 17.1. Germany Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tissue Engineered Skin Substitute Market

• 18.1. France Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tissue Engineered Skin Substitute Market

• 19.1. Italy Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tissue Engineered Skin Substitute Market

• 20.1. Spain Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tissue Engineered Skin Substitute Market

• 21.1. Eastern Europe Tissue Engineered Skin Substitute Market Overview
• 21.2. Eastern Europe Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tissue Engineered Skin Substitute Market

• 22.1. Russia Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tissue Engineered Skin Substitute Market

• 23.1. North America Tissue Engineered Skin Substitute Market Overview
• 23.2. North America Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tissue Engineered Skin Substitute Market

• 24.1. USA Tissue Engineered Skin Substitute Market Overview
• 24.2. USA Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tissue Engineered Skin Substitute Market

• 25.1. Canada Tissue Engineered Skin Substitute Market Overview
• 25.2. Canada Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tissue Engineered Skin Substitute Market

• 26.1. South America Tissue Engineered Skin Substitute Market Overview
• 26.2. South America Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tissue Engineered Skin Substitute Market

• 27.1. Brazil Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tissue Engineered Skin Substitute Market

• 28.1. Middle East Tissue Engineered Skin Substitute Market Overview
• 28.2. Middle East Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tissue Engineered Skin Substitute Market

• 29.1. Africa Tissue Engineered Skin Substitute Market Overview
• 29.2. Africa Tissue Engineered Skin Substitute Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Tissue Engineered Skin Substitute Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Tissue Engineered Skin Substitute Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tissue Engineered Skin Substitute Market Competitive Landscape And Company Profiles

• 30.1. Tissue Engineered Skin Substitute Market Competitive Landscape
• 30.2. Tissue Engineered Skin Substitute Market Company Profiles
  • 30.2.1. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. DePuy Synthes Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Smith & Nephew Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. ConvaTec Group PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Mallinckrodt Pharmaceuticals plc Overview, Products and Services, Strategy and Financial Analysis

31. Tissue Engineered Skin Substitute Market Other Major And Innovative Companies

• 31.1. Integra LifeSciences Holdings Corporation
• 31.2. Gunze Limited
• 31.3. Organogenesis Inc.
• 31.4. LifeNet Health Inc.
• 31.5. MiMedx Group Inc.
• 31.6. Vericel Corporation
• 31.7. AlloSource Inc.
• 31.8. Sientra Inc.
• 31.9. PolyNovo Limited
• 31.10. Avita Medical Limited
• 31.11. Tissue Regenix Group
• 31.12. Amarantus Bioscience Holdings Inc.
• 31.13. PolarityTE
• 31.14. Promethean LifeSciences Inc.
• 31.15. Regenicin Inc.

32. Global Tissue Engineered Skin Substitute Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tissue Engineered Skin Substitute Market

34. Recent Developments In The Tissue Engineered Skin Substitute Market

35. Tissue Engineered Skin Substitute Market High Potential Countries, Segments and Strategies

• 35.1 Tissue Engineered Skin Substitute Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Tissue Engineered Skin Substitute Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Tissue Engineered Skin Substitute Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33594_Tissue_Engineered_Skin_Substitute_GMR_2025